By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostics company T2 Biosystems today said it has closed its $23 million Series D financing round.

The funds will be used to support ongoing clinical trials and technology development as the company prepares to seek regulatory approval and commercialization of its T2MR diagnostic technology based on magnetic biosensor detection. The funding will also allow it to expand its partnering program, the Lexington, Mass.-based company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: human cytomegalovirus diversity, patterns of homologous recombination in E. coli, and more.

US lawmakers are considering eliminating the medical devices tax that is part of the Affordable Care Act.

Two research teams in China home in on a gene that gives rice a long, slender shape.

Marcia McNutt, the editor-in-chief of Science, has been nominated to become president of the US National Academy of Sciences.